Inhibition of Coxsackievirus B3 Replication by Small Interfering RNAs Requires Perfect Sequence Match in the Central Region of the Viral Positive Strand

Coxsackievirus B3 (CVB3) is the most common causal agent of viral myocarditis, but existing drug therapies are of limited value. Application of small interfering RNA (siRNA) in knockdown of gene expression is an emerging technology in antiviral gene therapy. To investigate whether RNA interference (...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Virol
Hoofdauteurs: Yuan, Ji, Cheung, Paul K. M., Zhang, Huifang M., Chau, David, Yang, Decheng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology (ASM) 2005
Onderwerpen:
Vaccines and Antiviral Agents
Online toegang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC546545/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15681418/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.79.4.2151-2159.2005
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items